Jacobson Pharma Announces FY2020 Interim Results
- Written by Reporters
- Profit Attributable to Shareholders Lifted by 30.5%
- Portfolio and Market Expansion to Harness Growth Potentials
HONG KONG, CHINA - Media OutReach - 26 November 2019 - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in research, development, production,...